Knowledge, attitude and practice of adverse drug reaction reporting among healthcare workers in a tertiary centre in Northern Nigeria

Tropical Journal of Pharmaceutical Research

Volumn 10, Issue 3, 2011, Pages 235-242

  Fadare, Joseph O ^a   Enwere, Okezie O ^b   Afolabi, A O ^a   Chedi, B A Z ^c   Musa, A ^c  

^a Kogi State Specialist Hospital   (Nigeria)

^b IMO STATE UNIVERSITY   (Nigeria)

^c BAYERO UNIVERSITY   (Nigeria)

Author keywords

Adverse drug reactions; Attitude and practice; Health care workers; Knowledge; Yellow card reporting scheme

Indexed keywords

ADULT; ARTICLE; CROSS-SECTIONAL STUDY; DRUG SURVEILLANCE PROGRAM; FEMALE; HEALTH CARE PERSONNEL; HEALTH PERSONNEL ATTITUDE; HOSPITAL PHYSICIAN; HUMAN; MALE; NIGERIA; NURSE; PHARMACIST; QUESTIONNAIRE; TEACHING HOSPITAL; TERTIARY HEALTH CARE;

EID: 79959993901     PISSN: 15965996     EISSN: 15969827     Source Type: Journal    
DOI: 10.4314/tjpr.v10i3.4     Document Type: Article

References (27)

1. Lazarou J, Pomeranz BH, Corey PN. Incidence of ADR in hospitalized patients: a meta-analysis of prospective studies. JAMA, 1998; 279:1000-1005
2. World Health Organization. Safety of Medicines. A guide to detecting and reporting adverse drug reactions. Geneva, Switzerland: World Health Organization 2002. WHO/EDM/QSM/2002.2
3. Moore N, Lecointre D, Noblet C, Mabille M. Frequency and cost of serious adverse drug reactions in a department of general medicine. Br J Clin Pharmacol 1998; 45: 301-308.
4. White TJ, Arakelian A, Rho JP. Counting the cost of drug-related adverse events. Pharmacoeconomics,1999; 15: 44-49
5. Waller PC. Making the most of spontaneous adverse drug reaction reporting. Basic Clin Pharmacol Toxicol. 2006; 98: 320-323.
6. Vallano A, Cereza G, Pedròs C, Agustí A, Danés I, Aguilera C, Arnau JM. Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital. Br J Clin Pharmacol. 2005; 60: 653-658.
7. Ulfvarson J, Mejyr S, Bergman U. Nurses are increasingly involved in pharmacovigilance in Sweden. Pharmacoepidemiol Drug Saf. 2007; 16: 532-537.
8. Ball D, Tisócki T. Adverse drug reaction reporting by general medical practitioners and retail pharmacists in Harare--a pilot study. Cent Afr J Med. 1998; 44: 190-195
9. Okezie OO, Fawole OI. Adverse drug reactions reporting by physicians in Ibadan, Nigeria. Pharmacoepidemiol Drug Saf. 2008; 17: 517-522.
10. Oshikoya KA, Awobusuyi JO. Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria. BMC Clin Pharmacol. 2009; 9:14
11. Ohaju-Obodo JO, Iribhogbe OI. Extent of pharmacovigilance among resident doctors in Edo and Lagos states of Nigeria. Pharmacoepidemiol Drug Saf. 2010; 19: 191-195.
12. Generali JA, Danish MA, Rosenbaum SE. Knowledge of and attitudes about adverse drug reaction reporting among Rhode Island pharmacists. Ann Pharmacother. 1995; 29: 365-369.
13. Valente S, Murray L, Fisher D. Nurses improve medication safety with medication allergy and adverse drug reports. J Nurs Care Qual. 2007; 22: 322-327.
14. Lopez-Gonzalez E, Herdeiro MT, Figueiras A. Determinants of under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2009; 32: 19-31. doi: 10.2165/00002018-200932010-00002.
15. Williams D, Feely J. Underreporting of adverse drug reactions: attitudes of Irish doctors. Ir J Med Sci. 1999; 168: 257-261.
16. Khoza S, Madungwe I, Nyambayo P, Mthethwa J, Chikuni O. Adverse drug reactions reporting at a referral hospital in Zimbabwe. Cent Afr J Med. 2004; 50: 104-107.
17. Belton KJ, Lewis SC, Payne S, Rawlins MD, Wood SM. Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom. Br J Clin Pharmacol. 1995; 39: 223-226.
18. Aziz Z, Siang TC, Badarudin NS. Reporting of adverse drug reactions: predictors of underreporting in Malaysia. Pharmacoepidemiol Drug Saf. 2007; 16: 223-228.
19. Nichols V, Thériault-Dubé I, Touzin J, Delisle JF, Lebel D, Bussières JF, Bailey B, Collin J. Risk perception and reasons for noncompliance in pharmacovigilance: a qualitative study conducted in Canada. Drug Saf. 2009; 32:579-590. doi: 10.2165/00002018-200932070-00004.
20. Hazell L, Shakir SA. Under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2006; 29: 385-396.
21. Li Q, Zhang SM, Chen HT, Fang SP, Yu X, Liu D, Shi LY, Zeng FD. Awareness and attitudes of healthcare professionals in Wuhan, China to the reporting of adverse drug reactions. Chin Med J (Engl). 2004; 117: 856-861
22. Toklu HZ, Uysal MK. The knowledge and attitude of the Turkish community pharmacists toward pharmacovigilance in the Kadikoy district of Istanbul. Pharm World Sci. 2008; 30: 556-562.
23. Vessal G, Mardani Z, Mollai M. Knowledge, attitudes, and perceptions of pharmacists to adverse drug reaction reporting in Iran. Pharm World Sci. 2009; 31: 183-187.
24. Bäckström M, Mjörndal T, Dahlqvist R. Spontaneous reporting of adverse drug reactions by nurses. Pharmacoepidemiol Drug Saf. 2000; 11: 647-650.
25. Bäckström M, Mjörndal T. A small economic inducement to stimulate increased reporting of adverse drug reactions-a way of dealing with an old problem? Eur J Clin Pharmacol. 2006; 62: 381-385.
26. Blenkinsopp A, Wilkie P, Wang M, Routledge PA. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience. Br J Clin Pharmacol. 2007; 63: 148-456
27. van Hunsel F, Passier A, van Grootheest K. Comparing patients' and healthcare professionals' ADR reports after media attention: the broadcast of a Dutch television programme about the benefits and risks of statins as an example. Br J Clin Pharmacol. 2009; 67: 558-564.